Novel 4-anilinoquinazolines with C-7 basic side chains: Design and structure activity relationship of a series of potent, orally active, VEGF receptor tyrosine kinase inhibitorsHENNEQUIN, Laurent F; STOKES, Elaine S. E; THOMAS, Andrew P et al.Journal of medicinal chemistry (Print). 2002, Vol 45, Num 6, pp 1300-1312, issn 0022-2623Article

ZD6474 inhibits vascular endothelial growth factor signaling, angiogenesis, and tumor growth following oral administrationWEDGE, Stephen R; OGILVIE, Donald J; GRAHAM, George A et al.Cancer research (Baltimore). 2002, Vol 62, Num 16, pp 4645-4655, issn 0008-5472Article

Design and campaign synthesis of piperidine-and thiazole-based histone deacetylase inhibitorsANDREWS, David M; STOKES, Elaine S. E; CARR, Greg R et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 8, pp 2580-2584, issn 0960-894X, 5 p.Article

Design and campaign synthesis of pyridine-based histone deacetylase inhibitorsANDREWS, David M; GIBSON, Keith M; GRAHAM, Mark A et al.Bioorganic & medicinal chemistry letters (Print). 2008, Vol 18, Num 8, pp 2525-2529, issn 0960-894X, 5 p.Article

A novel series of 4-piperidinopyridine and 4-piperidinopyrimidine inhibitors of 2,3-oxidosqualene cyclase-lanosterol synthaseBROWN, George R; HOLLINSHEAD, David M; WOOD, Robin et al.Journal of medicinal chemistry (Print). 2000, Vol 43, Num 26, pp 4964-4972, issn 0022-2623Article